123 related articles for article (PubMed ID: 35445907)
1. Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy.
Arnold DE; Chellapandian D; Parikh S; Mallhi K; Marsh RA; Heimall JR; Grossman D; Chitty-Lopez M; Murguia-Favela L; Gennery AR; Boulad F; Arbuckle E; Cowan MJ; Dvorak CC; Griffith LM; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson T; Kang EM; Malech HL; Leiding JW
J Clin Immunol; 2022 Jul; 42(5):1026-1035. PubMed ID: 35445907
[TBL] [Abstract][Full Text] [Related]
2. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.
Leiding JW; Arnold DE; Parikh S; Logan B; Marsh RA; Griffith LM; Wu R; Kidd S; Mallhi K; Chellapandian D; Si Lim SJ; Grunebaum E; Falcone EL; Murguia-Favela L; Grossman D; Prasad VK; Heimall JR; Touzot F; Burroughs LM; Bleesing J; Kapoor N; Dara J; Williams O; Kapadia M; Oshrine BR; Bednarski JJ; Rayes A; Chong H; Cuvelier GDE; Forbes Satter LR; Martinez C; Vander Lugt MT; Yu LC; Chandrakasan S; Joshi A; Prockop SE; Dávila Saldaña BJ; Aquino V; Broglie LA; Ebens CL; Madden LM; DeSantes K; Milner J; Rangarajan HG; Shah AJ; Gillio AP; Knutsen AP; Miller HK; Moore TB; Graham P; Bauchat A; Bunin NJ; Teira P; Petrovic A; Chandra S; Abdel-Azim H; Dorsey MJ; Birbrayer O; Cowan MJ; Dvorak CC; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson TR; Malech HL; Kang EM
Blood; 2023 Dec; 142(24):2105-2118. PubMed ID: 37562003
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.
Yanagimachi M; Kato K; Iguchi A; Sasaki K; Kiyotani C; Koh K; Koike T; Sano H; Shigemura T; Muramatsu H; Okada K; Inoue M; Tabuchi K; Nishimura T; Mizukami T; Nunoi H; Imai K; Kobayashi M; Morio T
Front Immunol; 2020; 11():1617. PubMed ID: 32849547
[TBL] [Abstract][Full Text] [Related]
4. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs LM; Skoda-Smith S; Chandrakasan S; Yu LC; Oshrine BR; Cuvelier GDE; Thakar MS; Chen K; Teira P; Shenoy S; Phelan R; Forbes LR; Chellapandian D; Dávila Saldaña BJ; Shah AJ; Weinacht KG; Joshi A; Boulad F; Quigg TC; Dvorak CC; Grossman D; Torgerson T; Graham P; Prasad V; Knutsen A; Chong H; Miller H; de la Morena MT; DeSantes K; Cowan MJ; Notarangelo LD; Kohn DB; Stenger E; Pai SY; Routes JM; Puck JM; Kapoor N; Pulsipher MA; Malech HL; Parikh S; Kang EM;
J Clin Immunol; 2019 Oct; 39(7):653-667. PubMed ID: 31376032
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Bielorai B; Toren A; Wolach B; Mandel M; Golan H; Neumann Y; Kaplinisky C; Weintraub M; Keller N; Amariglio N; Paswell J; Rechavi G
Bone Marrow Transplant; 2000 Nov; 26(9):1025-8. PubMed ID: 11100285
[TBL] [Abstract][Full Text] [Related]
6. The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.
Heim KF; Fleisher TA; Stroncek DF; Holland SM; Gallin JI; Malech HL; Leitman SF
Transfusion; 2011 Jun; 51(6):1154-62. PubMed ID: 21175646
[TBL] [Abstract][Full Text] [Related]
7. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
Tomblyn MR; Ewell M; Bredeson C; Kahl BS; Goodman SA; Horowitz MM; Vose JM; Negrin RS; Laport GG
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1051-7. PubMed ID: 21073974
[TBL] [Abstract][Full Text] [Related]
8. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
9. Outcome of chronic granulomatous disease - Conventional treatment vs stem cell transplantation.
Dedieu C; Albert MH; Mahlaoui N; Hauck F; Hedrich C; Baumann U; Warnatz K; Roesler J; Speckmann C; Schulte J; Fischer A; Blanche S; von Bernuth H; Kühl JS
Pediatr Allergy Immunol; 2021 Apr; 32(3):576-585. PubMed ID: 33118209
[TBL] [Abstract][Full Text] [Related]
10. Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency.
Lum SH; Selvarajah S; Deya-Martinez A; McNaughton P; Sobh A; Waugh S; Burton-Fanning S; Newton L; Gandy J; Nademi Z; Owens S; Williams E; Emonts M; Flood T; Cant A; Abinun M; Hambleton S; Gennery AR; Slatter M
J Allergy Clin Immunol; 2020 Aug; 146(2):406-416. PubMed ID: 32442647
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.
Connelly JA; Marsh R; Parikh S; Talano JA
J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S31-S39. PubMed ID: 29746680
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Alloimmunization after granulocyte transfusions.
Stroncek DF; Leonard K; Eiber G; Malech HL; Gallin JI; Leitman SF
Transfusion; 1996; 36(11-12):1009-15. PubMed ID: 8937413
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Stem Cell Transplantation Cures Therapy-refractory Aspergillosis in Chronic Granulomatous Disease.
Dedieu C; Landwehr-Kenzel S; Thee S; Oevermann L; Voigt S; Marggraf K; Schulte J; Lau S; Roesler J; Kuehl JS; von Bernuth H
Pediatr Infect Dis J; 2021 Jul; 40(7):649-654. PubMed ID: 34097656
[TBL] [Abstract][Full Text] [Related]
15. Improved Outcome Following Busulfan-Based Conditioning in Children with Functional Neutrophil Disorders Undergoing Hematopoietic Stem Cell Transplant from HLA-Matched Donors.
Jacoby E; Adam E; Hutt D; Somech R; Malkiel S; Toren A; Bielorai B
J Clin Immunol; 2023 Oct; 43(7):1603-1610. PubMed ID: 37310531
[TBL] [Abstract][Full Text] [Related]
16. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.
Güngör T; Teira P; Slatter M; Stussi G; Stepensky P; Moshous D; Vermont C; Ahmad I; Shaw PJ; Telles da Cunha JM; Schlegel PG; Hough R; Fasth A; Kentouche K; Gruhn B; Fernandes JF; Lachance S; Bredius R; Resnick IB; Belohradsky BH; Gennery A; Fischer A; Gaspar HB; Schanz U; Seger R; Rentsch K; Veys P; Haddad E; Albert MH; Hassan M;
Lancet; 2014 Feb; 383(9915):436-48. PubMed ID: 24161820
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium.
Rangarajan HG; Stanek JR; Abdel-Azim H; Modi A; Haight A; McKinney CM; McKeone DJ; Buchbinder DK; Katsanis E; Abusin GA; Ahmed I; Law J; Silva JG; Mallhi KK; Burroughs LM; Shah N; Shaw PJ; Greiner R; Shenoy S; Pulsipher MA; Abu-Arja R
Transplant Cell Ther; 2022 Jun; 28(6):329.e1-329.e9. PubMed ID: 35288346
[TBL] [Abstract][Full Text] [Related]
18. Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.
Parta M; Cuellar-Rodriguez J; Gea-Banacloche J; Qin J; Kelly C; Zerbe CS; Holland SM; Malech HL; Kang EM
Transpl Infect Dis; 2022 Apr; 24(2):e13815. PubMed ID: 35191140
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
Seger RA; Gungor T; Belohradsky BH; Blanche S; Bordigoni P; Di Bartolomeo P; Flood T; Landais P; Müller S; Ozsahin H; Passwell JH; Porta F; Slavin S; Wulffraat N; Zintl F; Nagler A; Cant A; Fischer A
Blood; 2002 Dec; 100(13):4344-50. PubMed ID: 12393596
[TBL] [Abstract][Full Text] [Related]
20. [A clinical study of haploid hematopoietic stem cells combined with third-party umbilical cord blood transplantation in the treatment of chronic granulomatous disease].
Tang XF; Lu W; Jing YF; Huang YZ; Wu NH; Luan Z
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):552-557. PubMed ID: 31208508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
